Pathos was borne from the belief that cancer is a collection of hundreds of rare diseases and can be best described by pathways accounting for the pathophysiology of patients. We license or co-develop clinical-stage therapeutics to ensure highly efficacious drugs are developed for the patients most likely to benefit and with significant unmet needs.
Our patient selection strategies are optimized for the fastest path to approval to improve patient outcomes as quickly as possible. Our aim is ultimately to accelerate the translation of real-world data into breakthrough therapies for patients that need them most.
Company Details
- Employees
- 88
- Founded
- -
- Address
- Chicago, Illinois , Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://pathos.com/
- Keywords
- AI, Biotechnology, Drug Development, Oncology, Precision Medicine, Cancer Biology, Data Science, Machine Learning, Clinical Trials, Drug Discovery, Precision Oncology, Biopharma, Pharma, Computational Biology.
- HQ
- Chicago, Illinois
Pathos Questions
Pathos's website is https://pathos.com/
Pathos's LinkedIn profile is https://www.linkedin.com/company/pathos-ai
Pathos has
88 employees.
View email and phone details for 88
employees at Pathos.
Pathos's industry is
Biotechnology Research
Pathos's top competitors are
Tempus Ai,
Matterworks,
Lightbank,
Arbor Biotechnologies,
Newlimit,
Olaris, Inc,
Known Medicine,
Dispatch Bio,
Proscia,
Click Therapeutics, Inc..
Pathos's categories are Biotechnology Research
Pathos's founding year is 2022
